These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 7755620

  • 1. Bioactive synthetic peptide of NDF/heregulin.
    Kita Y, Mayer J, Zamborelli T, Hara S, Rohde M, Watson E, Koski R, Ratzkin B, Nicolson M.
    Biochem Biophys Res Commun; 1995 May 16; 210(2):441-51. PubMed ID: 7755620
    [Abstract] [Full Text] [Related]

  • 2. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 May 16; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 3. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
    Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S.
    Nature; 1993 Dec 02; 366(6454):473-5. PubMed ID: 7902537
    [Abstract] [Full Text] [Related]

  • 4. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP, Langton BC, Dilts CA.
    Mol Carcinog; 1996 Feb 02; 15(2):134-43. PubMed ID: 8599580
    [Abstract] [Full Text] [Related]

  • 5. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
    Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R.
    Oncogene; 1999 Jan 14; 18(2):305-14. PubMed ID: 9927187
    [Abstract] [Full Text] [Related]

  • 6. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG, Kokeny KE, Dilts CA, Ethier SP.
    J Cell Physiol; 1995 Jun 14; 163(3):589-96. PubMed ID: 7775601
    [Abstract] [Full Text] [Related]

  • 7. NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
    Kita YA, Barff J, Luo Y, Wen D, Brankow D, Hu S, Liu N, Prigent SA, Gullick WJ, Nicolson M.
    FEBS Lett; 1994 Jul 25; 349(1):139-43. PubMed ID: 8045292
    [Abstract] [Full Text] [Related]

  • 8. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 9. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
    Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE.
    Cancer Res; 1997 Sep 01; 57(17):3804-11. PubMed ID: 9288791
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells.
    Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D.
    Oncogene; 1995 Jan 05; 10(1):167-75. PubMed ID: 7824269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 17. HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins.
    Culouscou JM, Carlton GW, Aruffo A.
    J Biol Chem; 1995 May 26; 270(21):12857-63. PubMed ID: 7759543
    [Abstract] [Full Text] [Related]

  • 18. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
    Kunz C, Borghouts C, Buerger C, Groner B.
    Mol Cancer Res; 2006 Dec 26; 4(12):983-98. PubMed ID: 17189388
    [Abstract] [Full Text] [Related]

  • 19. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F.
    Oncogene; 2001 Apr 19; 20(17):2101-11. PubMed ID: 11360194
    [Abstract] [Full Text] [Related]

  • 20. Homologue scanning mutagenesis of heregulin reveals receptor specific binding epitopes.
    Harris A, Adler M, Brink J, Lin R, Foehr M, Ferrer M, Langton-Webster BC, Harkins RN, Thompson SA.
    Biochem Biophys Res Commun; 1998 Oct 09; 251(1):220-4. PubMed ID: 9790934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.